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Abstract
Background: During the manufacture of tungsten metal for non-sag wire, tungsten oxide powders are produced
as intermediates and can be in the form of tungsten trioxide (WO3) or tungsten blue oxides (TBOs). TBOs contain
fiber-shaped tungsten sub-oxide particles of respirable or thoracic size. The aim of this research was to investigate
whether fiber-containing TBOs had prolonged biodurability in artificial lung fluids compared to tungsten metal or
WO3 and therefore potentially could pose a greater inhalation hazard.
Methods: Dissolution of tungsten metal, WO3, one fiber-free TBO (WO2.98), and three fiber-containing TBO (WO2.81,
WO2.66, and WO2.51) powders were measured for the material as-received, dispersed, and mixed with metallic
cobalt. Solubility was evaluated using artificial airway epithelial lining fluid (SUF) and macrophage phagolysosomal
simulant fluid (PSF).
Results: Dissolution rates of tungsten compounds were one to four orders of magnitude slower in PSF compared
to SUF. The state of the fiber-containing TBOs did not influence their dissolution in either SUF or PSF. In SUF, fiber-
containing WO2.66 and WO2.51 dissolved more slowly than tungsten metal or WO3. In PSF, all three fiber-containing
TBOs dissolved more slowly than tungsten metal.
Conclusions: Fiber-containing TBO powders dissolved more slowly than tungsten metal and WO3 powders in SUF
and more slowly than tungsten metal in PSF. Existing pulmonary toxicological information on tungsten
compounds indicates potential for pulmonary irritation and possibly fibrosis. Additional research is needed to fully
understand the hazard potential of TBOs.
Introduction
Tungsten is a naturally occurring element that has
industrial value in the form of its metal, oxide, and salts.
One estimate suggests that up to 800,000 workers may
be exposed to tungsten compounds in the United States
[1]. One common application of tungsten metal is non-
sag wire for light bulb filaments [2]. The production of
non-sag wire involves calcination of ammonium para-
tungstate to yield tungsten oxide powder intermediates
which are subsequently reduced under controlled condi-
tions to yield tungsten metal powder for making wire
filaments. The type of tungsten oxide intermediate pro-
duced depends on the calcination conditions, including
furnace atmosphere. Yellow tungsten trioxide (WO3) is
produced if sufficient air is supplied whereas tungsten
blue oxides (TBOs) having varying chemical and
physical properties are produced under non-equilibrium
conditions when air is excluded. TBO is not a well-
defined compound; rather, it is a blue-colored mixture
of crystalline hexagonal tungsten bronzes, WO3, and
various non-stoichiometric tungsten sub-oxides and an
amorphous oxide [2,3].
During production of TBOs, aerosols are generated
which contain tungsten sub-oxides with fiber-shaped
morphology. In a Swedish tungsten refining and manu-
facturing facility, airborne tungsten oxide fibers had
respirable size, length (L) ≥ 5 μm, diameter (D) ≤ 3 μm,
and aspect ratio = L/D (AR) ≥ 5:1; the physical diameter
of most fibers was ≤0.3 μm [4]. Both single fibers and
aggregates of fibers were observed in Swedish workplace
atmospheres [4-6]. In the United States, greater than
95% of airborne tungsten-containing fibers collected
during tungsten refining and manufacturing and hard
metal production had thoracic size (i.e., aerodynamic
diameter (Dae) ≤ 10 μm) [1,7].
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The toxicity of fibers is influenced by their dimension,
durability, and dose (at the target tissue). Fiber dimen-
sions determine the extent to which fibers are inhaled,
retained, and cleared by the lung. In humans engaged in
mouth breathing, deposition in the alveolar region of
the lung is maximal for fibers having Dae of 2 μm and
AR of 3 to 20. Biopersistence is determined by the rate
at which fibers are physically cleared from the lung by
mechanical action (macrophage- or mucocilliary-
mediated) and the rate at which they are dissolved (i.e.,
biodurability) in lung fluids [8,9]. Fibers longer than 20
μm that deposit on the surface of conducting airways
are cleared by mechanical (i.e., mucociliary) action.
Because fibers longer than 20 μm that deposit in the
unciliated terminal bronchioles or alveoli are not cleared
from their deposition site by mucociliary action and
probably cannot be engulfed and cleared by a single
macrophage, they will likely remain in the lung if bio-
durable. Engulfment by macrophages of fibers with
length between 5 and 20 μm may inhibit macrophage
mobility in a graded fashion. Mechanical clearance of
fibers shorter than 5 μm by lung alveolar macrophages
is probably not influenced by fiber length [8,9]. Fiber
chemistry, in part, determines biodurability, as does the
lung fluid pH [8,9].
Keith et al. [10], in a U.S. Agency for Toxic Sub-
stances and Disease Registry (ATSDR) literature review,
has reported the health effects from inhalation of tung-
sten compounds which has focused almost exclusively
on non-fibrous forms. In one study, rats that inhaled
tungsten carbide or were intratracheally instilled with
tungsten metal or WO3 developed mild pulmonary
fibrosis [10]; another rat intratrachial instillation study
reported that WO3 did not affect release of biomarkers
linked to fibrosis [11]. Aamodt [12] exposed beagle dogs
by nose-only inhalation to WO3 particles and deter-
mined that 33% of the lung-deposited dose entered the
systemic circulation, either via dissolution of particles in
lung fluid or translocation to the systemic circulation by
alveolar macrophages. In some workers exposed to
mixed dusts containing tungsten, the tungsten-contain-
ing particles that deposit in the alveolar region of the
lung persist for years [13]. Workers in the cemented
tungsten carbide industry can be exposed to several
tungsten compounds, including the metal, carbide, and
tungstenate which vary in their solubility in the body
[14]. Only one study investigated tungsten oxide fibers.
In this in vitro study, laboratory-prepared tungsten
oxide fibers, intended to mimic TBO materials, were
observed to generate free radicals which could poten-
tially contribute to development of pulmonary fibrosis
[15]. Thus, the potential for adverse health effects fol-
lowing inhalation of fiber-shaped tungsten oxide parti-
cles is not understood. Given the role of fiber-shaped
particles in lung toxicity we investigated whether fiber-
containing TBOs are more durable in artificial lung
fluids than tungsten metal or WO3 and therefore poten-
tially could pose a greater inhalation hazard.
Materials and methods
Study overview
The objective of this study was to evaluate whether
TBO fibers had prolonged biodurability in artificial lung
fluids compared to tungsten metal or WO3. Hence, the
dissolution of each tungsten oxide powder was mea-
sured in the “as-received” (aggregated), “dispersed” (indi-
vidual particles), and mechanically mixed (with cobalt)
states using two different artificial lung fluids. Dissolu-
tion of a pure fine tungsten metal and a fine cobalt
metal obtained from a hard metal producer [16] were
also measured to benchmark durability of the tungsten
oxides.
Fibers may induce different pathological effects for
aggregated and dispersed forms of the same material.
Shvedova et al. [17] reported that aggregated single-
walled carbon nanotubes (SWCNT) were associated
with induction of granulomas in mouse lung (dosing by
pharyngeal aspiration), but dispersed SWCNT were
associated with diffuse interstitial fibrosis and alveolar
wall thickening. McKernan et al. [1] detected tungsten-
containing fibers in a hard metal production facility,
indicating potential for exposure to these airborne fibers
beyond the intermediate stages of tungsten metal pro-
duction. The presence of cobalt is known to enhance
the toxicity of tungsten carbide by generating larger
amounts of free radicals than equivalent masses of
cobalt or tungsten carbide alone [18]. Thus, we mea-
sured dissolution for each aggregated powder mixed
with cobalt at a ratio of 95:5 by weight. These admix-
tures do not represent any specific industrial powder
formulations but were created to understand the co-
dissolution of tungsten in the presence of cobalt.
Study powders
Five bulk tungsten oxide powders were provided for
study by an industrial producer of non-sag tungsten
metal wire: yellow WO3 and the TBOs WO2.98, WO2.81,
WO2.66, and WO2.51. The only defined tungsten oxide is
WO3; the TBOs were manufactured under non-equili-
brium conditions and the oxidative states of these
powders are average values. The WO2.98 is crystallogra-
phically WO3, but has oxygen defects that impart a
blue-color to the material. WO2.81 is a mixture of
WO2.90 and WO2.72, whereas both WO2.66 and WO2.51
are mixtures of varying proportions of WO2.72 and
WO2. The WO3 and WO2.98 powders were examined
microscopically as described below and consisted of iso-
metric-shaped particles and accounted for approximately
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80% of this manufacturer’s production. The WO2.81,
WO2.66, and WO2.51 powders were examined microsco-
pically and were mixtures of isometric and fiber particle
morphologies and accounted for the remaining 20% of
industrial production.
Study powder characterization
A field emission scanning electron microscope (SEM;
model S-4800, Hitachi, Tokyo, Japan) was used to evalu-
ate morphology, aggregation state, and external dimen-
sions of the as received and dispersed powders (see
Figure 1). Powders were dispersed using distilled water
and deposited onto a 0.025 μm pore-size nitrocellulose
filter [19]. Helium pycnometry was used to determine
powder density by gas displacement (AccuPyc II 1340
Analyzer, Micromeritics, Norcross, GA). Nitrogen gas
adsorption was used to determine powder specific sur-
face area (SSA) using a multipoint Brunauer, Emmett,
and Teller (BET) instrument (Quadrasorb surface area
analyzer, Quantachrome, Boynton Beach, FL). Prior to
analysis, powders were outgassed under vacuum (0.013
torr) at 200°C overnight to remove moisture [20].
The U.S. National Institute for Occupational Safety
and Health (NIOSH) Method 7400 with “B” counting
rules was used to count tungsten-containing fibers, i.e.,
L > 5 μm, D < 3 μm, and AR of ≥5:1 [1,7]. The relative
mass fractions of isometric- and fiber-shaped particles
in each powder was calculated from measures of 150 to
300 particle external dimensions in 27 to 50 microscope
fields per material and the measured density. The orien-
tation-averaged fiber Dae was calculated as described by
Griffiths and Vaughn [21]. For isometric-shaped parti-
cles, Dae was calculated assuming a dynamic shape fac-
tor (c) of 1.08 for cube-shaped WO3 and WO2.98
particles and c of 1.00 for spherical tungsten and cobalt
particles [22].
Total C, H, and N impurity content [23,24] and S
impurity content [25] of powders were determined by
combustion by a commercial laboratory (Galbraith
Laboratories, Knoxville, TN). Oxygen content was
assayed by pyrolysis (LECO Corp, St. Joseph, MI).
Inductively coupled plasma (ICP)-atomic emission spec-
troscopy was used to quantify metal impurities in accor-
dance with NIOSH Method 7303: Elements by ICP [26].
X-ray photoelectron spectroscopy was used to evaluate
powder surface (top 20 Å) chemistry (McCrone Associ-
ates, Westmont, IL).
Artificial Lung Fluid Dissolution Studies
Dissolution of triplicate samples of each powder was
evaluated using a static technique [27]. Known masses
(in the range 10 to 100 mg) of each study powder were
determined gravimetrically using a calibrated five-place
balance (Model AX 205, Mettler Toledo, Greifensee,
Figure 1 Scanning electron micrographs of study powders:
“as-received” (A) W metal, (B) Co metal, (C) WO3, (D) WO2.98,
(E) WO2.81, (F) WO2.66, and (G) WO2.51 powders. The W and Co
powders were agglomerates of primary particles, the WO3 and
WO2.98 powders were cube-shaped isometric particle morphology,
and the WO2.81, WO2.66, and WO2.51 powders were mixtures of fiber-
and cube-shaped particle morphologies; “dispersed” (E1) WO2.81, (F1)
WO2.66, and (G1) WO2.51 powders illustrating individual fiber
morphology. Note that the scale bars differ among images.
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Switzerland) capable of reading to 10 μg. Each static dis-
solution chamber was placed in a separate polypropy-
lene cup, immersed in 80 mL of artificial lung fluid,
covered with a lid having two holes to allow gas
exchange, and maintained at 37 °C throughout an
experiment.
Serum ultrafiltrate (SUF) was used to model dissolu-
tion in lung airway epithelial lining fluid [28]. This sol-
vent consists of chloride (217.5 mM), sodium (145.7
mM), ammonium (100.0 mM), calcium (29.4 mM),
bicarbonate (27.0 mM), cysteine (1.1 mM), phosphate
(1.0 mM). sulfate (0.6 mM), citrate (0.2 mM), and
diethylenetriaminepentaacetic acid (2 mM), the latter to
prevent formation of insoluble phosphate precipitates.
The pH of SUF was maintained at 7.4 ± 0.1 by blanket-
ing the headspace in each sample with 5% CO2 and 95%
air. Masses of dissolved tungsten were measured after 1,
3, 6, 12, 24, 36, 48, and 72 hours to mimic the residence
time of particles in extracellular lung fluid [29]. Phagoly-
sosomal simulant fluid (PSF) buffered with 0.02 M
potassium hydrogen phthalate was used to model disso-
lution in lung alveolar macrophages [30]. This solvent
consists of sodium (116.8 mM), chloride (114.2 mM),
potassium (25.0 mM), glycine (6.0 mM), phosphate (1.0
mM), sulfate (0.5 mM), and calcium (0.2 mM). The pH
of PSF remained at 4.5 ± 0.1 throughout experiments.
Masses of dissolved tungsten were measured at 1, 4, 8,
12, 24, and 72 hours, and then twice weekly thereafter
to 31 days to mimic the approximate lifespan of an
alveolar macrophage [31]. In pilot studies, alkylbenzyldi-
methylammonium chloride, added to artificial lung
fluids to prevent mold growth, inhibited dissolution of
some tungsten oxide powders and was omitted from the
full-scale experiments. Rather, mold growth was pre-
vented by using sterile labware and laboratory practices.
Experimental and quality control samples were ana-
lyzed using U.S. Occupational Safety and Health Admin-
istration Method 213: Tungsten and Cobalt in
Workplace Atmospheres: inductively coupled plasma
analysis [32]. Analysis of dissolved tungsten was per-
formed using inductively coupled plasma-atomic emis-
sion spectroscopy (ICP-AES) without sample digestion.
The analytical limit of detection (LOD) for tungsten in
SUF was 0.03 mg L-1 and the limit of quantification
(LOQ) was 0.11 mg L-1. For PSF, the tungsten LOD was
0.08 μg L-1 and the LOQ was 0.27 μg L-1. Undissolved
particulate in the dissolution chambers exposed to SUF
and PSF were digested and masses of tungsten quanti-
fied using ICP-AES; the tungsten LOD was 0.1 μg sam-
ple-1 and the LOQ was 0.43 μg sample-1.
Data analyses
Dissolution parameters for isometric-shaped powders
(W, WO3 and WO2.98) were calculated using a surface-
area-limited dissolution model [33]. Dissolution para-
meters for fiber-containing powders (WO2.81, WO2.66,





















is the mass fraction of material remaining,
t is time (days), d0 is the average initial fiber diameter
(μm) from SEM analysis, r is the measured fiber density
(g/cm3), and k is the chemical dissolution rate constant







2 were plotted versus
time and non-linear least squares regression models
used to estimate the best fit line for the data. The slope
value, b, for this line was used to calculate t1/2 (i.e.,
-0.693/b) and to estimate k (i.e., b/SSA).
For WO2.81 and WO2.51 in PSF, dissolution data were
best described by two negative exponentials, i.e., both a
shorter term and a longer term dissolution behavior (see
Figure 2B). For these specific cases, a two-part segmen-
ted regression model was used to determine the point at
which the shorter term phase ended and the longer
term phase began [35].







2 were plotted versus time; however,
only the linear portion of the segmented regression,
which corresponded to the longer-term dissolution
phase was used to calculate dissolution parameters. The
slope of the best fit line from the plotted data, b, was
used to calculate t1/2 and k as noted above.
Analysis of variance F-statistics were used to identify
overall differences in dissolution half-times and mean
rate constants among materials. Tukey’s test was used
to identify differences between paired means.
Results
Figure 1 illustrates the morphology of the tungsten
oxide study powders. The W and Co powders were both
clusters of spherical primary particles. In the as-received
state, the WO3 and WO2.98 powders were large, com-
pact, mostly cube-shaped particles. The WO2.81, WO2.66,
and WO2.51 powders were mixtures of compact cube-
shaped and fiber-shaped particles. Dispersed WO2.81
and WO2.51 both contained long, thin fibers and cube-
shaped particles, whereas WO2.66 contained short, cylin-
der-shaped and cube-shaped particles.
Table 1 summarizes the physical properties of the study
powders. Measured density values for the well-defined
WO3.00 and W were near theoretical values. The mea-
sured density value for Co was slightly lower than
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theoretical due to the presence of less dense cobalt oxide
on particle surfaces as previously determined using
Auger spectroscopy [36]. For the TBO powders, density
generally increased as powder oxygen content (density
1.3 g/cm3) decreased relative to the tungsten content
(density 19.2 g/cm3) per unit volume of powder. SSA,
which depends on particle diameter, density, and surface
characteristics (roughness, pores, etc), varied by up to a
factor of 15 among powders. Among the WO2.81,
WO2.66, and WO2.51 powders, geometric mean (GM)
physical fiber lengths were 6 to 8 μm and diameters were
≤0.5 μm. The WO2.81 and WO2.51 powders were 80%
fibers by mass. In contrast, for WO2.66 powder, many
particles were cylinder-shaped, but only 38% met the
definition for a fiber using NIOSH B counting rules.
Tungsten oxide powder surfaces were composed of
tungsten and oxygen with minor amounts of carbon,
which is consistent with tungsten oxides. Measured oxy-
gen content of the well-defined WO3 material was
greater than 95% of that predicted from the formula
weight. The measured oxygen contents of the WO2.98,
WO2.81, WO2.66, and WO2.51 powders were 19 ± 3%, 19
± 0%, 16 ± 1%, and 16 ± 4%, respectively, which are
consistent with the masses expected from the average
stoichiometries of the powder constituents. The oxygen
content of the tungsten metal study powder was <0.3%.
Levels of impurities in the tungsten oxide materials
were either below analytical LODs or ≤0.001% by weight
(Sb, Ba, Cr, Cu, Fe, Se, and V).
Dissolution results
In general, tungsten dissolution from each study powder
consisted of a single phase that was best described by a
single negative exponential. For a few powder/solvent
combinations, dissolution was biphasic, consisting of an
initial rapid dissolution phase followed by a long-term
dissolution phase; these data were best described by two
negative exponentials. The fraction of material dissolved
Figure 2 Plots of tungsten oxide powder dissolution for the
as-received state in phagolysosomal simulant fluid.
(A) isometric-shaped WO3 and WO2.98 powders illustrating single-
phase dissolution that was best described by a single negative
exponential. Dissolution parameters were calculated using a
surface-area-limited dissolution model [33]. Note that the y-axis
scale is mass fraction remaining (M/M0) and plotted values from
0.90 to 1.0 to illustrate the shape of the curves. (B) fiber-
containing WO2.81, WO2.66, and WO2.51 powders; WO2.81 and
WO2.51 illustrate biphasic dissolution that was described by two
negative exponentials (the first for the initial rapid dissolution
phase and the second for the latter long-term phase) whereas
WO2.66 was best described by a single negative exponential.
Dissolution parameters for the fiber-containing materials were
calculated using a constant dissolution velocity model [34]. Note
that the y-axis is 1 - (M/M0) and plotted values range from 0.0 to
0.15 to illustrate the shapes of the curves; hence, the fraction of
material dissolved during the initial phase was low, usually less
than 2% of the total.
Table 1 Physical properties of study powders
Dphys (μm)
a Lphys (μm) Lphys/Dphys Dae (μm) Mass (%)
b
Powder Density (g/cm3) SSA (m2/g) AM ± SD GM (GSD) AM ± SD GM (GSD) GM AM ± SD GM (GSD) I F
WO3 7.2 ± 0.0 0.75 ± 0.03 36.2 ± 20.4 31.1 (1.8) –
c – – 94 ± 53 80.4 (1.8) 100 0
WO2.98 7.0 ± 0.0 11.10 ± 0.76 37.5 ± 26.0 29.8 (2.0) – – – 95 ± 66 75.8 (2.0) 100 0
WO2.81 7.1 ± 0.0 2.85 ± 0.02 0.3 ± 0.3 0.2 (2.0) 8.8 ± 5.6 7.8 (1.6) 38 1.7 ± 1.4 1.4 (1.8) 21 79
WO2.66 8.2 ± 0.0 1.50 ± 0.07 0.5 ± 0.1 0.5 (1.1) 6.3 ± 0.7 6.3 (1.1) 12 3.1 ± 0.3 3.1 (1.1) 62 38
WO2.51 7.7 ± 0.1 2.10 ± 0.02 0.5 ± 0.2 0.5 (1.5) 7.6 ± 3.0 7.2 (1.4) 15 3.0 ± 0.9 2.9 (1.4) 21 79
W 19.2 ± 0.1 0.68 ± 0.09 2.5 ± 1.9 2.0 (2.0) – – – 11.1 ± 8.1 8.8 (2.0) 100 0
Co 8.2 ± 0.1 7.30 ± 0.24 2.4 ± 1.7 1.9 (1.9) – – – 6.8 ± 4.9 5.5 (1.9) 100 0
a Dphys = physical diameter; Lphys = physical length; Dae = aerodynamic diameter. Dae values in the Table are orientation-averaged values for the fiber-shaped
fractions of the WO2.81, WO2.66, and WO2.51 powders). Calculated Dae values for the isometric-shaped particle fraction of the WO2.81, WO2.66, and WO2.51 powders
are 2.5 ± 1.5, 7.5 ± 6.0, and 3.7 ± 1.8 μm, respectively.
b Particles having isometric (I)- or fiber (F)-shaped morphology.
c – Not applicable for materials of isometric morphology only.
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during the initial phase was low, usually less than 2% of
the total, so reported dissolution rates refer only to the
long-term phase (see Figure 2).
Artificial airway epithelial lining fluid
Table 2 summarizes the fitted long-term dissolution
parameters for the tungsten oxide powders in three
states (as-received, dispersed, and mixed with cobalt)
for a 72-hour immersion in SUF. In the as-received
state, values of t1/2 for the fiber-containing WO2.51 and
WO2.66 powders were longer and their corresponding
k values were slower compared to all other powders (p
< 0.05). In the dispersed state, values of t1/2 for the
fiber-containing WO2.51 and WO2.66 powders were
longer than for the other tungsten oxide powders (p <
0.05). Dispersed fiber-containing WO2.81, WO2.66, and
WO2.51 powders had slower k values than the iso-
metric-shaped WO3 and WO2.98 powders (p < 0.05).
Dissolution of cobalt in SUF was biphasic and inde-
pendent of the presence of any tungsten oxide powder
(data not shown). The dissolution half-time for WO2.98
was shortest among all tungsten oxide/cobalt powder
mixtures (p < 0.05). There were no differences in k
values among the tungsten oxide powders mixed with
cobalt.
For a given fiber-containing tungsten oxide powder, k
values in SUF did not differ among the as-received, dis-
persed, and mixture states. Dissolution rates (k-values)
for the isometric-shaped WO3 and WO2.98 powders did
not differ between the as-received and dispersed states;
however, in the presence of cobalt their rates were
slower.
Artificial alveolar macrophage phagolysosomal fluid
Table 3 summarizes the fitted long-term dissolution
parameters for the tungsten-containing powders during
31 days of immersion in PSF. In general, dissolution
rates of tungsten oxides in PSF were one to four orders
of magnitude slower than in SUF. In the as-received
state, t1/2 ranged from 97 days (W) to 9893 days (WO3)
with the rank order (from longest to shortest) being:
WO3 ≈ WO2.98 ≈ WO2.81 ≈ WO2.51 > WO2.66 > W (p <
0.05). The corresponding rank order of k values (from
fastest to slowest) was: W > WO2.66 > WO3 ≈ WO2.98 ≈
WO2.81 ≈ WO2.51 (p < 0.05). In the as-received state,
the k value for W metal was faster than that for WO2.66
and the rates for these two compounds were both faster
than the rates for the remaining tungsten oxides (p <
0.05). In the dispersed state, t1/2 values ranged from
hundreds to thousands of days; WO2.66 was significantly
faster than all other oxide powders. The dissolution rate
for dispersed fiber-containing WO2.66 powder was faster
than rates for all other dispersed tungsten oxide pow-
ders (p < 0.05). There was no difference in k values
among the dispersed WO3, WO2.98, WO2.81, and
WO2.51 powders. In the powder mixtures, dissolution of
cobalt was independent of tungsten oxide (data not
shown). When mixed with cobalt, t1/2 values for the
tungsten oxide powders ranged from 200 to 8000 days;
WO2.66 was significantly faster than all other oxide pow-
ders. The corresponding k-value for WO2.66 powder was
faster than all other tungsten oxide powders (p < 0.05).
For a given tungsten oxide powder, values of t1/2 did
not differ among states in PSF with the exception of a
longer half-time for WO3 in the dispersed state than in
the as-received and mixed states. For a given powder, its
k-values did not differ among states in PSF.
Discussion
The rate at which materials are cleared from the respira-
tory tract depends upon the location in which the mate-
rial deposits, the physicochemical form of the material,
and the time since deposition [37]. In the present study,
dissolution was evaluated for tungsten oxides having
varying physicochemical properties in two artificial lung
environments, one mimicking the fluid lining the air-
ways (i.e., SUF) and the other mimicking the fluid con-
tained in alveolar macrophage phagolysosomes (i.e.,
PSF). Clear differences in dissolution behavior were
observed among and within tungsten oxide powders in
Table 2 Long-term dissolution parameters (mean ± standard deviation) for tungsten-containing materials after
immersion in artificial airway epithelial lining fluid (pH 7.4) for 72 hours
As Received Dispersed Mixture with Cobalt
Powder t1/2 (days) k [g/(cm
2·day)] t1/2 (days) k [g/(cm
2day)] t1/2 (days) k [g/(cm
2·day)]
WO3 4 ± 1 2.5 ± 0.3 × 10
-5 11a 0.9 × 10-5 79 ± 23 1.3 ± 0.4 × 10-6
WO2.98 1 ± 0 6.0 ± 1.2 × 10
-6 1 ± 0 6.0 ± 2.3 × 10-6 10 ± 2 6.5 ± 1.6 × 10-7
WO2.81 11 ± 2 2.3 ± 0.3 × 10
-6 13 ± 1 1.9 ± 0.1 × 10-6 71 ± 6 3.5 ± 0.3 × 10-7
WO2.66
b 56 ± 10 8.4 ± 1.7 × 10-7 41 ± 2 1.1 ± 0.1 × 10-6 72 ± 22 6.8 ± 1.8 × 10-7
WO2.51 81 ± 4 4.1 ± 0.2 × 10
-7 50 ± 14 6.9 ± 1.7 × 10-7 89 ± 13 3.8 ± 0.6 × 10-7
W 19 ± 2 5.4 ± 0.5 × 10-6 –c – – –
a Result for WO3 in dispersed state is for n = 1 sample.
b Values for t1/2 (days) and k [g/(cm
2·day)] calculated using surface-area-limited dissolution model: 30 ± 6, 1.6 ± 0.3 × 10-6 (as-received); 22 ± 2, 2.1 ± 0.2 × 10-6
(dispersed); 37 ± 11, 1.3 ± 0.3 × 10-6 (mixture).
c Not applicable for the tungsten metal samples.
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SUF and PSF. Such differences are important for under-
standing the relative persistence of tungsten oxides in
the lung.
Mechanical clearance half-times for durable particles
that deposit in the conducting airways are approximately
8 hours (bronchioles to bronchi), 100 minutes (bronchi
to extrathoracic airways), and 10 minutes (extrathoracic
airways to the gastrointestinal tract) via the mucociliary
escalator [37]. In SUF, the as-received and dispersed
WO3 and WO2.98 had the fastest dissolution rates
among all the studied powders, though the presence of
cobalt slowed dissolution of these materials. Based on
the measured surface area and dissolution rates, the
amounts of material dissolved from WO3 in each of the
above-listed clearance half-times would be 6% (8 hours),
1% (100 minutes), and 0.1% (10 minutes), whereas the
amounts of material dissolved from WO2.98 would be
20% (8 hours), 5% (100 minutes), and 0.5% (10 minutes).
Thus, clearance of these materials from the conducting
airways would include both mechanical action and dis-
solution. The WO3 and WO2.98 powders are crystallo-
graphically similar materials and the high solubility of
these materials supports the results of Aamodt [12],
who observed that approximately one-third of an
inhaled WO3 particle dose enters systemic circulation.
Interestingly, in all states evaluated, WO2.66 dissolved
faster in SUF than the other fiber-containing samples
which may be due to its higher mass fraction of iso-
metric-shaped particles (Table 1). However, in all states
evaluated, the fiber-containing tungsten oxide powders
dissolved more slowly than the isometric-shaped materi-
als. This suggests that clearance of fiber-containing
tungsten oxide powders from the conducting airways
would be dominated by mechanical mechanisms with
little (<1%) dissolving during a single clearance half-
time.
The orientation-averaged Dae and aspect ratios of
the WO2.81, WO2.66, and WO2.51 fibers indicate that
they were respirable, with high probability of deposi-
tion in the non-ciliated alveolar region of the lung
(Table 1). The dimensions of fibers in these bulk
tungsten oxide powders are consistent with previous
reports that airborne tungsten oxide fibers in work-
place atmospheres had respirable or thoracic size
[1,4,7]. Within 24 hours, 90% of particles deposited in
the alveolar region of the lung are associated with
macrophage cells [29]. The lengths of the WO2.81,
WO2.66, and WO2.51 fibers ranged from 6 to 9 μm,
which is sufficient to inhibit their clearance from
alveoli by macrophages [8,9]. As such, dissolution in
macrophage phagolysosomal fluid is likely to play an
important role in the clearance of relatively insoluble
materials such as TBO fibers that deposit in the alveo-
lar region of the lung.
Often, rate of metal dissolution increases as solvent
pH decreases [38]. However, in the current study, disso-
lution rates of each tungsten oxide material were up to
four orders of magnitude slower in PSF than in SUF,
indicating potential for long-term retention of tungsten
oxides that deposit in the alveolar region of the lung.
With regards to dissolution in PSF, the fiber-containing
WO2.81, WO2.66, and WO2.51 powders dissolved more
slowly in the as-received state than tungsten metal pow-
der, indicating potential for longer persistence in the
alveoli. In the dispersed and mixed states, WO2.66 pow-
der, but not WO2.81 or WO2.51 powder, dissolved more
rapidly than the other tungsten oxide powders. Overall,
these results suggest that fiber-containing tungsten oxi-
des that deposit in the alveolar region of the lung would
have similar biopersistence to isometric-shaped WO3
and WO2.98, but would be more biopersistent than
tungsten metal.
The toxicity of tungsten compounds provides limited
clues as to potential adverse effects from inhalation of
tungsten oxide fibers. Workers that grind cemented
tungsten carbides are exposed to mixed dusts containing
tungsten, which persists in the alveoli for years [13].
Workers in the cemented tungsten carbide industry are
exposed to several tungsten compounds which have a
range of solubility in the body [14]. WO3 was reported
Table 3 Long-term dissolution parameters (mean ± standard deviation) for tungsten-containing materials after
immersion in artificial lung alveolar macrophage phagolysosomal fluid (pH 4.5) for 31 days
As Received Dispersed Mixture with Cobalt
Powder t1/2 (days) k [g/(cm
2·day)] t1/2 (days) k [g/(cm
2·day)] t1/2 (days) k [g/(cm
2·day)]
WO3 9893 ± 2549 9.8 ± 2.9 × 10
-9 21541 ± 1890 4.3 ± 0.4 × 10-9 8052 ± 2458 1.1 ± 0.4 × 10-8
WO2.98 656 ± 154 9.9 ± 2.6 × 10
-9 929 ± 45 6.8 ± 0.3 × 10-9 655 ± 72 9.6 ± 1.0 × 10-9
WO2.81 2218 ± 84 1.1 ± 0.0 × 10
-8 2207 ± 144 1.1 ± 0.1 × 10-8 2084 ± 102 1.2 ± 0.1 × 10-8
WO2.66
a 181 ± 7 2.6 ± 0.1 × 10-7 214 ± 6 2.2 ± 0.1 × 10-7 218 ± 17 2.1 ± 0.2 × 10-7
WO2.51 2455 ± 422 1.4 ± 0.2 × 10
-8 2915 ± 414 1.1 ± 0.2 × 10-8 1343 ± 252 2.5 ± 0.5 × 10-8
W 97 ± 17 1.1 ± 0.2 × 10-6 –b – – –
a Values for t1/2 (days) and k [g/(cm
2·day)] calculated using surface-area-limited dissolution model: 87 ± 4, 5.3 ± 0.2 × 10-7 (as-received); 106 ± 3, 4.4 ± 0.1 × 10-7
(dispersed); 101 ± 8, 4.6 ± 0.4 × 10-7 (mixture).
b Not applicable for the tungsten metal samples
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to cause mild pulmonary fibrosis in rats [10], though
this effect was not confirmed in another study [11].
Laboratory-prepared TBO materials can generate free
radicals at rates higher than asbestos in vitro, which
could contribute to development of pulmonary fibrosis
[15] though it is unknown whether this reaction occurs
in vivo. Tungsten oxide fibers can be present in work-
places that use cobalt [1] and cobalt is known to
enhance the toxicity of some tungsten compounds by
generating free radicals [18]. In the current study, the
dissolution rates of each fiber-containing tungsten oxide
powder did not differ among the as-received, dispersed,
and cobalt mixture states. Hence, whether inhaled as
tungsten oxide or tungsten oxide/cobalt mixtures, these
powders will persist in the alveoli and present opportu-
nity for generation of free radicals. Shvedova et al. [17]
reported that dispersed SWCNT were associated with
diffuse interstitial fibrosis and aggregated SWCNT
induced granulomas in mouse lung. Particle dispersion
may variably influence in vivo biopersistence in relation
to the capacity of macrophages to engulf agglomerated
versus individual fibers. In the current study, there were
no differences in dissolution rates between as-received
and dispersed tungsten oxide fibers. The potential for
adverse health effects due to long-term persistence of
tungsten oxide fibers in the alveolar region of the lung
remains poorly understood.
Finally, it is interesting to note that historically, an early
method for producing non-sag tungsten metal wire
involved reduction of WO3. Later, in the 1970 s, industrial
producers began to use TBOs because these materials have
higher surface area and therefore are better at absorbing
potassium ions, which are important for product perfor-
mance [2]. While the TBOs are better at absorbing potas-
sium ions, WO3 can be made to have the same surface
area as TBOs and high-quality wire can be produced using
WO3 [3]. The WO3 material evaluated in this study had a
mean equivalent Dae of approximately 100 μm, much lar-
ger than the Dae of the three fiber-containing TBOs. Thus,
when inhaled, the WO3 material evaluated in this study
would be more likely to deposit in the more rapidly cleared
upper conducting airways and less likely to be deposited in
the more slowly cleared alveolar regions of the lung. Also,
the WO3 material evaluated in this study was more soluble
than the three fiber-containing TBOs evaluated in this
study. In light of the measured particle physical character-
istics and observed dissolution data, in vivo studies to eval-
uate toxicity of TBOs relative to WO3 powder may be
worthwhile to determine whether substitution of WO3 for
TBOs is appropriate.
Summary
The current study focused on the durability of three fiber-
containing tungsten oxide powders in artificial lung fluids
and compared their dissolution behavior to tungsten
metal and two isometric-shaped tungsten oxide powders.
Dissolution rates of tungsten compounds were one to four
orders of magnitude slower in PSF compared to SUF. The
physical state of the tungsten oxides (as-received versus
dispersed) had no effect on dissolution behavior in either
SUF or PSF. The presence of cobalt did not influence dis-
solution of the fiber-containing tungsten oxide powders;
however, dissolution rates of WO3 and WO2.98 in SUF
were slowed by cobalt. Compared to tungsten metal pow-
der, a known mild pulmonary irritant, dissolution rates of
fiber-containing WO2.66 and WO2.51 powders were slower
in SUF and dissolution rates of all three fiber-containing
TBO powders were slower in PSF. The slow dissolution of
tungsten oxide fibers, coupled with existing toxicology
information on tungsten compounds, suggests additional
research is needed to fully understand the hazard potential
of these fibers.
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